Effect of Ascorbic acid on hematologic status among Pregnant women, attending antenatal clinic in Phramongkutklao hospital
Phase 1
Recruiting
- Conditions
- Healthy pregnant womenNo hematological diasease
- Registration Number
- TCTR20201105006
- Lead Sponsor
- Phramongkutklao College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Pregnant women, aged ≥18 years, attending antenatal clinic of Phramongkutklao hospital
Singleton pregnancy
Hematocrit ≥33 mg%
Gestational age 14-18 week
Exclusion Criteria
Drug allergy : Ascorbic acid, Ferrous fumarate
Chronic disease ex. chronic infection, autoimmune disease (especially RA), kidney disease, or cancerDrug allergy : Ascorbic acid, Ferrous fumarate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maternal Hematologic status in pregnancy Pre intervention hematocrit value and post intervention hematocrit value at 12 week after interventi Pre intervention hematocrit value and post intervention hematocrit value
- Secondary Outcome Measures
Name Time Method Demographics data affect to iron deficiency anemia Demographics data at pre intervention date Demographics data of volunteer , example age, occupation, education, underlying disease